Literature DB >> 17067279

The functional impact of SLC6 transporter genetic variation.

Maureen K Hahn1, Randy D Blakely.   

Abstract

Solute carrier 6 (SLC6) is a gene family of ion-coupled plasma membrane cotransporters, including transporters of neurotransmitters, amino acids, and osmolytes that mediate the movement of their substrates into cells to facilitate or regulate synaptic transmission, neurotransmitter recycling, metabolic function, and fluid homeostasis. Polymorphisms in transporter genes may influence expression and activity of transporters and contribute to behavior, traits, and disease. Determining the relationship between the monoamine transporters and complex psychiatric disorders has been a particular challenge that is being met by evolving approaches. Elucidating the functional consequences of and interactions among polymorphic sites is advancing our understanding of this relationship. Examining the influence of environmental influences, especially early-life events, has helped bridge the gap between genotype and phenotype. Refining phenotypes, through assessment of endophenotypes, specific behavioral tasks, medication response, and brain network properties has also improved detection of the impact of genetic variation on complex behavior and disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17067279     DOI: 10.1146/annurev.pharmtox.47.120505.105242

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  57 in total

Review 1.  The solute carrier 6 family of transporters.

Authors:  Stefan Bröer; Ulrik Gether
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

2.  Substrate-induced unlocking of the inner gate determines the catalytic efficiency of a neurotransmitter:sodium symporter.

Authors:  Christian B Billesbølle; Mie B Krüger; Lei Shi; Matthias Quick; Zheng Li; Sebastian Stolzenberg; Julie Kniazeff; Kamil Gotfryd; Jonas S Mortensen; Jonathan A Javitch; Harel Weinstein; Claus J Loland; Ulrik Gether
Journal:  J Biol Chem       Date:  2015-09-11       Impact factor: 5.157

3.  Strain dependent gene expression and neurochemical levels in the brain of zebrafish: focus on a few alcohol related targets.

Authors:  Y Pan; D Chatterjee; R Gerlai
Journal:  Physiol Behav       Date:  2012-02-01

4.  Structure-based discovery of prescription drugs that interact with the norepinephrine transporter, NET.

Authors:  Avner Schlessinger; Ethan Geier; Hao Fan; John J Irwin; Brian K Shoichet; Kathleen M Giacomini; Andrej Sali
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-01       Impact factor: 11.205

5.  An N-terminal threonine mutation produces an efflux-favorable, sodium-primed conformation of the human dopamine transporter.

Authors:  Rheaclare Fraser; Yongyue Chen; Bipasha Guptaroy; Kathryn D Luderman; Stephanie L Stokes; Asim Beg; Louis J DeFelice; Margaret E Gnegy
Journal:  Mol Pharmacol       Date:  2014-04-21       Impact factor: 4.436

Review 6.  Personality as an intermediate phenotype for genetic dissection of alcohol use disorder.

Authors:  Lars Oreland; Gianvito Lagravinese; Simone Toffoletto; Kent W Nilsson; Jaanus Harro; C Robert Cloninger; Erika Comasco
Journal:  J Neural Transm (Vienna)       Date:  2017-01-04       Impact factor: 3.575

7.  Computation-guided analysis of paroxetine binding to hSERT reveals functionally important structural elements and dynamics.

Authors:  Ara M Abramyan; Rachel D Slack; Sitaram Meena; Bruce A Davis; Amy Hauck Newman; Satinder K Singh; Lei Shi
Journal:  Neuropharmacology       Date:  2018-11-01       Impact factor: 5.250

Review 8.  The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited.

Authors:  Jordy van Enkhuizen; David S Janowsky; Berend Olivier; Arpi Minassian; William Perry; Jared W Young; Mark A Geyer
Journal:  Eur J Pharmacol       Date:  2014-08-05       Impact factor: 4.432

Review 9.  The SLC6 transporters: perspectives on structure, functions, regulation, and models for transporter dysfunction.

Authors:  Gary Rudnick; Reinhard Krämer; Randy D Blakely; Dennis L Murphy; Francois Verrey
Journal:  Pflugers Arch       Date:  2013-12-13       Impact factor: 3.657

10.  Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter.

Authors:  Ali Salahpour; Amy J Ramsey; Ivan O Medvedev; Brian Kile; Tatyana D Sotnikova; Ericka Holmstrand; Valentina Ghisi; Peter J Nicholls; Ling Wong; Karen Murphy; Susan R Sesack; R Mark Wightman; Raul R Gainetdinov; Marc G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.